Hunt for ‘holy grail’ of stroke treatment

Share this article
Have your say

Medical researchers are seeking the “holy grail” of stroke treatment in an attempt to break new ground for patients.

The Glasgow-based team hopes to extend the amount of time viable brain tissue, known as the penumbra, can be treated around the “dead” area after stroke.

Currently clinicians use clot-busting drugs in a treatment only licensed for use up to four-and-a-half hours after a stroke.

Dr Celestine Santosh, neuroradiologist at the Southern General Hospital, said: “This obviously has major limitations as one-third of all stroke patients don’t know the time of their onset of symptoms. However, research shows that the penumbra can stay viable up to 48 hours after a stroke

“Therefore accurately identifying the penumbra is really the holy grail in stroke.”